Tanaka H - Search Results

1

A case of late variant form of infantile Krabbe disease with a partial deficiency of galactocerebrosidase.

Okada S, Kato T, Tanaka H, Takada K, Aramitsu Y. Okada S, et al. Among authors: tanaka h. Brain Dev. 1988;10(1):45-6. doi: 10.1016/s0387-7604(88)80045-7. Brain Dev. 1988. PMID: 3369670

2

Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection.

Takada K, Oh-Hashi M, Yoshikawa H, Muranishi S, Nishiyama M, Yoshida H, Hata T, Tanaka H. Takada K, et al. Among authors: tanaka h. J Chromatogr. 1990 Aug 24;530(1):212-8. doi: 10.1016/s0378-4347(00)82324-5. J Chromatogr. 1990. PMID: 1703552 No abstract available.

3

Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats.

Takada K, Usuda H, Oh-Hashi M, Yoshikawa H, Muranishi S, Tanaka H. Takada K, et al. Among authors: tanaka h. J Pharmacobiodyn. 1991 Jan;14(1):34-42. doi: 10.1248/bpb1978.14.34. J Pharmacobiodyn. 1991. PMID: 1713626

4

Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.

Hirose A, Kato T, Ohno Y, Shimizu H, Tanaka H, Nakamura M, Katsube J. Hirose A, et al. Among authors: tanaka h. Jpn J Pharmacol. 1990 Jul;53(3):321-9. doi: 10.1254/jjp.53.321. Jpn J Pharmacol. 1990. PMID: 1975278 Free article.

5

Binding profile of SM-9018, a novel antipsychotic candidate.

Kato T, Hirose A, Ohno Y, Shimizu H, Tanaka H, Nakamura M. Kato T, et al. Among authors: tanaka h. Jpn J Pharmacol. 1990 Dec;54(4):478-81. doi: 10.1254/jjp.54.478. Jpn J Pharmacol. 1990. PMID: 1982326 Free article.

6

Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.

Nakajima S, Yamaoka K, Yamamoto T, Okada S, Tanaka H, Seino Y. Nakajima S, et al. Among authors: tanaka h. Bone Miner. 1990 Sep;10(3):201-9. doi: 10.1016/0169-6009(90)90262-e. Bone Miner. 1990. PMID: 2171704

7

Lack of hepatotoxicity or promotion of enzyme-altered liver foci development in rats treated with harman or norharman.

Hagiwara A, Tanaka H, Kurata Y, Kato T, Tsuda H, Ito N. Hagiwara A, et al. Among authors: tanaka h. J Toxicol Environ Health. 1990;29(2):211-8. doi: 10.1080/15287399009531384. J Toxicol Environ Health. 1990. PMID: 2299694

8

Tuberous sclerosis: aberrant proline sensitivity of skin fibroblasts.

Hayashi A, Tanaka H, Arima M. Hayashi A, et al. Among authors: tanaka h. Brain Dev. 1989;11(3):161-3. doi: 10.1016/s0387-7604(89)80090-7. Brain Dev. 1989. PMID: 2568764

9

Muscle histopathology in spastic cerebral palsy.

Ito J, Araki A, Tanaka H, Tasaki T, Cho K, Yamazaki R. Ito J, et al. Among authors: tanaka h. Brain Dev. 1996 Jul-Aug;18(4):299-303. doi: 10.1016/0387-7604(96)00006-x. Brain Dev. 1996. PMID: 8879649

10

Total synthesis of WS9326A, a potent tachykinin antagonist from Streptomyces violaceoniger.

Shigematsu N, Kayakiri N, Okada S, Tanaka H. Shigematsu N, et al. Among authors: tanaka h. Chem Pharm Bull (Tokyo). 1997 Feb;45(2):236-42. doi: 10.1248/cpb.45.236. Chem Pharm Bull (Tokyo). 1997. PMID: 9118439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,305 results

Search Page

Filters